Outcome of Sports Events May Depend on Circadian Rhythms
|
By LabMedica International staff writers Posted on 10 Feb 2015 |

Image: Graphical summary of a new study showing that athletic performance (and therefore sport event outcome) also depends on the circadian rhythms of individual athletes (Photo courtesy of University of Birmingham and Cell Press).
According to a new study, the outcome of sporting events may depend on how well the timing of the match aligns with the internal biological clocks of the athletes, and so could change performance by the hour depending on what time it is for their inner clock.
The study, conducted by researchers at University of Birmingham (Birmingham, England), found that diurnal performance of competition-level athletes varied by as much as 26% over the course of the day. Those who would naturally sleep in gave their best performances hours later in the day than early birds. Athletes and coaches would do well to make note and adjust their schedules accordingly as much as possible, the researchers said.
"If a 1% difference in performance can make the difference between 1st place and 4th place in a 100 meter race and actually win you the gold medal at the Olympics, then imagine what a 26% difference in your performance could give," said principal investigator Dr. Roland Brandstaetter. There were earlier reports that suggested that athletes' personal best performances are generally in the evening. But those studies did not account for whether those athletes were of night “owl” or morning “lark” phenotypes. While an individual's circadian phenotype often does shift from childhood into adolescence and adulthood, there are real physiological differences between people based on their natural sleep/wake patterns. These differences result in disparities between their biological clocks and how they entrain to exogenous cues, such as the environmental light/dark cycle and social factors.
In this study, a novel approach was used to characterize the circadian phenotypes of more than 120 athletes. Then 20 athletes were selected representing early, intermediate, and late phenotypes and tested their cardiovascular endurance in a standard fitness test at 6 times of day.
The fitness tests revealed considerable diurnal variation in individual performance. Rather than time-of-day, the best predictor of how well those groups performed at a given hour was the amount of time elapsed since their entrained awakening (i.e., the time since they would have woken up if left to their own devices, without an alarm clock). While an early riser may be at his or her best in the early afternoon, a late riser hits his or her peak much later at night.
The researchers concluded that “determination of an athlete's personal best performance requires consideration of circadian phenotype, performance evaluation at different times of day, and analysis of performance as a function of time since entrained awakening.” This would also be relevant for non-athletic performance – "Obtaining a personal best performance is on everyone's agenda, but how to do it, now that is a different question," said co-author Elise Facer-Childs, and suggested that people would be well-advised to shift significant attention from the clock on the wall to the one that's ticking inside.
The study, by Facer-Childs E. and Brandstaetter R., was published January 29, 2015, in the Cell Press journal Current Biology.
Related Links:
University of Birmingham
The study, conducted by researchers at University of Birmingham (Birmingham, England), found that diurnal performance of competition-level athletes varied by as much as 26% over the course of the day. Those who would naturally sleep in gave their best performances hours later in the day than early birds. Athletes and coaches would do well to make note and adjust their schedules accordingly as much as possible, the researchers said.
"If a 1% difference in performance can make the difference between 1st place and 4th place in a 100 meter race and actually win you the gold medal at the Olympics, then imagine what a 26% difference in your performance could give," said principal investigator Dr. Roland Brandstaetter. There were earlier reports that suggested that athletes' personal best performances are generally in the evening. But those studies did not account for whether those athletes were of night “owl” or morning “lark” phenotypes. While an individual's circadian phenotype often does shift from childhood into adolescence and adulthood, there are real physiological differences between people based on their natural sleep/wake patterns. These differences result in disparities between their biological clocks and how they entrain to exogenous cues, such as the environmental light/dark cycle and social factors.
In this study, a novel approach was used to characterize the circadian phenotypes of more than 120 athletes. Then 20 athletes were selected representing early, intermediate, and late phenotypes and tested their cardiovascular endurance in a standard fitness test at 6 times of day.
The fitness tests revealed considerable diurnal variation in individual performance. Rather than time-of-day, the best predictor of how well those groups performed at a given hour was the amount of time elapsed since their entrained awakening (i.e., the time since they would have woken up if left to their own devices, without an alarm clock). While an early riser may be at his or her best in the early afternoon, a late riser hits his or her peak much later at night.
The researchers concluded that “determination of an athlete's personal best performance requires consideration of circadian phenotype, performance evaluation at different times of day, and analysis of performance as a function of time since entrained awakening.” This would also be relevant for non-athletic performance – "Obtaining a personal best performance is on everyone's agenda, but how to do it, now that is a different question," said co-author Elise Facer-Childs, and suggested that people would be well-advised to shift significant attention from the clock on the wall to the one that's ticking inside.
The study, by Facer-Childs E. and Brandstaetter R., was published January 29, 2015, in the Cell Press journal Current Biology.
Related Links:
University of Birmingham
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more







 Analyzer.jpg)
